| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |